The Reuters report comes after Gordon Haskett's Don Bilson in February pointed out that QuidelOrtho ( QDEL ) may be a takeover target or a candidate for an activist investor as the company terminated its CEO. The diagnostics firm in February announced that Douglas Bryant, President and CEO, was terminated and he resigned from the board. Michael Iskra was appointed as the Interim CEO, and Robert Bujarski as the interim president.